Stock Track | Medpace Plunges 10% in Pre-Market on Lowered Revenue Guidance

Stock Track

Oct 22, 2024

Shares of Medpace Holdings Inc. (MEDP) plummeted over 10% in pre-market trading on Tuesday, October 22, as the clinical contract research organization lowered its revenue guidance for the full year 2024.

The company now expects revenue for 2024 to range between $2.09 billion and $2.13 billion, down from its previous guidance of $2.125 billion to $2.175 billion. Despite the lower revenue outlook, Medpace raised its earnings guidance for the year.

The revised guidance, which disappointed investors, led to a sharp sell-off in Medpace's stock during the pre-market session. The company's shares were trading at around $170, down over 10% from the previous close, reflecting the market's reaction to the lowered revenue expectations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1119487034"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1119487034\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1119487034?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-22 20:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1119487034","market":"hk","top_or_hot":-1,"title":"Stock Track | Medpace Plunges 10% in Pre-Market on Lowered Revenue Guidance","media":"Stock Track","content":"<p>Shares of Medpace Holdings Inc. (MEDP) plummeted over 10% in pre-market trading on Tuesday, October 22, as the clinical contract research organization lowered its revenue guidance for the full year 2024.</p>\n\n<p>The company now expects revenue for 2024 to range between $2.09 billion and $2.13 billion, down from its previous guidance of $2.125 billion to $2.175 billion. Despite the lower revenue outlook, Medpace raised its earnings guidance for the year.</p>\n\n<p>The revised guidance, which disappointed investors, led to a sharp sell-off in Medpace's stock during the pre-market session. The company's shares were trading at around $170, down over 10% from the previous close, reflecting the market's reaction to the lowered revenue expectations.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Medpace Plunges 10% in Pre-Market on Lowered Revenue Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Medpace Plunges 10% in Pre-Market on Lowered Revenue Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2024-10-22 20:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Medpace Holdings Inc. (MEDP) plummeted over 10% in pre-market trading on Tuesday, October 22, as the clinical contract research organization lowered its revenue guidance for the full year 2024.</p>\n\n<p>The company now expects revenue for 2024 to range between $2.09 billion and $2.13 billion, down from its previous guidance of $2.125 billion to $2.175 billion. Despite the lower revenue outlook, Medpace raised its earnings guidance for the year.</p>\n\n<p>The revised guidance, which disappointed investors, led to a sharp sell-off in Medpace's stock during the pre-market session. The company's shares were trading at around $170, down over 10% from the previous close, reflecting the market's reaction to the lowered revenue expectations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MEDP","symbol_name":"Medpace Holdings Inc.","start_time":0,"source_url":"","article_id":"1119487034","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1119487034","pubTimestamp":1729598534,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Medpace Holdings Inc.  plummeted over 10% in pre-market trading on Tuesday, October 22, as the clinical contract research organization lowered its revenue guidance for the full year 2024.The company now expects revenue for 2024 to range between $2.09 billion and $2.13 billion, down from its previous guidance of $2.125 billion to $2.175 billion. Despite the lower revenue outlook, Medpace raised its earnings guidance for the year.The revised guidance, which disappointed investors, led to","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MEDP":"Medpace Holdings Inc."},"translate_title":"由于收入指引下调，股票跟踪Medpace盘前暴跌10%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MEDP":1},"content_text":"Shares of Medpace Holdings Inc. (MEDP) plummeted over 10% in pre-market trading on Tuesday, October 22, as the clinical contract research organization lowered its revenue guidance for the full year 2024.\nThe company now expects revenue for 2024 to range between $2.09 billion and $2.13 billion, down from its previous guidance of $2.125 billion to $2.175 billion. Despite the lower revenue outlook, Medpace raised its earnings guidance for the year.\nThe revised guidance, which disappointed investors, led to a sharp sell-off in Medpace's stock during the pre-market session. The company's shares were trading at around $170, down over 10% from the previous close, reflecting the market's reaction to the lowered revenue expectations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}